ANALYSIS OF THE INFLUENCE OF HBSAG DETECTION RESULTS ON THE INTERPRETATION OF ANTI-HBC RESULTS IN THE DIAGNOSIS OF HEPATITIS B INFECTION
DOI:
https://doi.org/10.47701/78ywbv17Keywords:
HBsAg, anti-HCV, Hepatitis B, Hepatitis C, Co-infection, Chi-SquareAbstract
This study aims to analyze the relationship between Hepatitis C Virus Antibody (anti-HCV) test results using the ELISA method and Hepatitis B surface Antigen (HBsAg) test results using the rapid test method. HBV and HCV co-infection is a clinically relevant issue as it can accelerate the progression of chronic liver disease. Data from 62 patient samples were analyzed using the Chi-Square test to examine the significance of the relationship between these two categorical variables. The statistical analysis revealed a Chi-Square value of 3.89 with a P-value of 0.048, which is below the 0.05 significance level. This finding indicates a statistically significant association between the HBsAg and anti-HCV test results. This study concludes that in the sampled population, a reactive result on one test is associated with reactivity on the other, highlighting the importance of dual screening for both viruses in high-risk populations.
References
Chen, C. H., & Chen, D. S. (2022). Peran HBsAg dan Anti-HBc dalam Penatalaksanaan Hepatitis B Kronis. Hepatologi Klinis dan Molekuler, 28(1), 1–10. https://doi.org/10.3350/cmh.2022.0018
Liu, J., & Zhang, Q. (2024). Koinfeksi Hepatitis B dan C: Epidemiologi dan Tatalaksana Klinis. Klinik Penyakit Menular Amerika Utara, 38(2), 287–304. https://doi.org/10.1016/j.idc.2023.12.001
Lok, A. S. F., & McMahon, B. J. (2020). Hepatitis B Kronis: Perspektif Global. Hepatologi, 71(1), 120–130. https://doi.org/10.1002/hep.30888
Martin, N. K., & Vickerman, P. (2025). Beban Global Infeksi Virus Hepatitis B. Lancet Infectious Diseases, 25(3), 330–338. https://doi.org/10.1016/S1473-3099(24)00956-0
Pramonodjati, F., Arini, L. D. D., & Pasha, E. I. (2025). Pengaruh Hasil Pemeriksaan Hbsag Dengan Menggunakan Spesimen Darah Lengkap, Serum Dan Plasma. Prosiding Seminar Informasi Kesehatan Nasional (Sikesnas) 2025.
Rahmawati, S., & Hidayati, N. (2022). Ko-infeksi Hepatitis B dan C: Epidemiologi dan Penanganannya. Jurnal Penyakit Dalam, 12(3), 112–118.
Setiawan, A. (2023). Peran HBsAg dan Anti-HBc dalam Manajemen Hepatitis B. Jurnal Ilmu Kesehatan, 8(1), 15–22.
Terrault, N. A., Lok, A. S. F., & McMahon, B. J. (2021). Pedoman AASLD untuk Pengobatan Hepatitis B Kronis. Hepatologi, 73(6), 1851–1863. https://doi.org/10.1002/hep.31853
Wang, C., & Liu, S. (2025). Kemajuan Terkini dalam Penelitian Hepatitis B. Nature Reviews Gastroenterology & Hepatology, 22(1), 18–29. https://doi.org/10.1038/s41575-024-00568-7
Wong, R. S. M., & Chan, H. L. Y. (2021). Koinfeksi Hepatitis B dengan Virus Hepatitis C: Implikasi Klinis. Jurnal Hepatitis Virus, 28(6), 823–830. https://doi.org/10.1111/jvh.13458
Zhang, Y., Xu, Y., & Chen, X. (2024). Pentingnya Skrining Ganda untuk Hepatitis B dan C. Penelitian Hepatologi, 54(6), 398–405. https://doi.org/10.1111/hepr.13567